Clinical Trial Update: Empagliflozin in Patients With Glomerulonephritis [Phase 3]

View source ↗

Summary

Phase 3 trial update for empagliflozin in glomerulonephritis with proteinuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Proteinuria

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Glomerulonephritis, Proteinuria | Phase 3 | Status: COMPLETED